SFS
SGMO

Sowell Financial Services’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Sowell Financial Services’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,000
Closed -$10K – 2334
2021
Q1 		$10K Sell
1,000
-535
-35% -$7.21K ﹤0.01% 2329
2020
Q4 		$24K Buy
1,535
+535
+54% +$6.27K ﹤0.01% 1663
2020
Q3 		$9K Sell
1,000
-500
-33% -$5.41K ﹤0.01% 1842
2020
Q2 		$13K Buy
1,500
+500
+50% +$4.64K ﹤0.01% 1606
2020
Q1 		$6K Buy
+1,000
New +$7.42K ﹤0.01% 1781

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sowell Financial Services's SGMO Position: Q2 2021 in Review

Sowell Financial Services sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2021, closing a stake of 1,000 shares — an estimated $10K sold.

Sowell Financial Services first reported a position in SGMO in Q1 2020 and held it in 5 quarters. The position peaked at $24K in Q4 2020. 197 funds tracked by Wall St. Rank hold SGMO as of Q2 2021.

  • Sowell Financial Services reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,000 SANGAMO THERAPEUTICS INC shares in Q2 2021, an estimated $10K.
  • Sowell Financial Services first reported a position in SANGAMO THERAPEUTICS INC in Q1 2020 and held it in 5 quarters.
  • Sowell Financial Services's SANGAMO THERAPEUTICS INC position peaked at $24K in Q4 2020.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.